Stoyanova Lab News
Dr. Alifiani Hartono presents her project “CDC7 is a targetable regulator of advanced prostate cancer”
Dr. Alifiani Hartono presented her project “CDC7 is a targetable regulator of advanced prostate cancer” for her poster session at the 2024 AACR.
Dr. Tanya Stoyanova gives a talk at 2024 AACR on “UCHL1 as a Molecular indicator and therapeutic target for neuroendocrine carcinomas”
Dr. Stoyanova gave a talk on a project “UCHL1 as a Molecular Indicator and Therapeutic Target for Neuroendocrine Carcinomas” at the 2024 AACR.
Nakea Pennant receives 2024 AACR Minority Scholar in Cancer Award
Nakea Pennant, a PhD candidate at Clark-Atlanta University and a participant in the 2023 Clark-Atlanta University-UCLA DMMP Summer Research Program, won the 2024 AACR Minority Scholar in Cancer Award with her project “CXCR4/CB2 Antagonizes CXCR4-mediated metastasis in Tumor Growth in-vivo”.
Congratulations, Nakea!
Exciting News: Dr. Shiqin (Laura) Liu is promoted to Assistant Adjunct Professor
Dr. Shiqin Liu has been promoted to Assistant Adjunct Professor at the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles!
Congratulations Laura!
Biofabrication of prostate cancer-like 3D models utilizing co-axial hydrogel spinning
Stoyanova lab is excited to share our new publication in Biofabrication on using Co-axial hydrogel spinning technology for facile biofabrication of 3D prostate cancer models, in collaboration with Dr. Utkan Demirci’s lab.
Congratulations!
Link to Publication: https://iopscience.iop.org/article/10.1088/1758-5090/ad2535
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas
Stoyanova lab is excited to share our new publication on Cell Reports Medicine on revealing mechanisms of UCHL1 function in regulating the progression of neuroendocrine carcinomas and identifying UCHL1 as a therapeutic target and potential molecular indicator for diagnosing and monitoring treatment responses in these malignancies.
Congratulations!
Link to Publication: https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(23)00610-9.pdf
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker
Stoyanova lab is excited to share our new work on identifying Trop2 protein as a novel prognostic tissue biomarker and non-invasive urinary biomarker for prostate cancer.
Congratulations!
Link to Publication: https://www.nature.com/articles/s41598-023-50215-z
Welcome Hyeonji Hwang, a postdoctoral scholar from Seoul National University, to the lab!
Welcome to Dr. Stoyanova’s lab, Hyeonji!
Exciting News: Dr. Shiqin (Laura) Liu Receives Eula and Donald S. Coffey Innovative Research Award
Dr. Shiqin (Laura) Liu receives the Eula and Donald S. Coffey Innovative Research Award for her research discoveries and talk “UCHL1 is a Molecular Indicator and a Therapeutic Target for Neuroendocrine Prostate Cancer” at the Society for Basic Urological Research (SBUR) annual conference.
Congratulations, Laura!
